AI could transform pharmacovigilance

As someone who practiced pharmacy for over a decade, medication safety was always front and center.

Adverse drug reactions, polypharmacy risks, interaction cascades — these are everyday realities.

Traditionally, pharmacovigilance is reactive:
An adverse event occurs → it gets reported → signals are analyzed later.

But with modern data infrastructure, we could move toward predictive safety monitoring.

For example:
• Modeling interaction risk based on patient clusters
• Predicting high-risk adherence patterns
• Detecting early lab trends before toxicity
• Monitoring drift in prescribing behavior

Healthcare AI should strengthen medication safety — not just optimize operational metrics.

Curious how others see the role of predictive modeling in pharmacovigilance.

If you’re interested in deeper discussions, join:
https://www.reddit.com/r/HealthDataScience2AI/

Open to remote collaborations in healthcare analytics and digital health.